Detalles de la búsqueda
1.
Effectiveness and tolerability of camrelizumab combined with molecular targeted therapy for patients with unresectable or advanced HCC.
Cancer Immunol Immunother
; 72(7): 2137-2149, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36840762
2.
Inhibition of Ras protein activator like 2 produces antitumor effects in gastric cancer via the suppression of YAP1 activation.
Environ Toxicol
; 37(3): 527-538, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34826200
3.
α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.
J Cell Mol Med
; 24(1): 760-771, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31762191
4.
Machine Learning-based Development and Validation of a Cell Senescence Predictive and Prognostic Signature in Intrahepatic Cholangiocarcinoma.
J Cancer
; 15(9): 2810-2828, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38577599
5.
Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells.
J Exp Clin Cancer Res
; 40(1): 14, 2021 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33407730
6.
Apatinib inhibits pancreatic cancer growth, migration and invasion through the PI3K/AKT and ERK1/2/MAPK pathways.
Transl Cancer Res
; 10(7): 3306-3316, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35116637
7.
Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: an adjusted indirect meta-analysis and systematic review.
Ther Adv Med Oncol
; 12: 1758835920940932, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32728393
8.
Recombinant Dual-target MDM2/MDMX Inhibitor Reverses Doxorubicin Resistance through Activation of the TAB1/TAK1/p38 MAPK Pathway in Wild-type p53 Multidrug-resistant Breast Cancer Cells.
J Cancer
; 11(1): 25-40, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31892970
9.
Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.
Cancer Biol Ther
; 20(5): 617-632, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30462562
10.
The Clinical Significance of PD-L1/PD-1 Expression in Gastroenteropancreatic Neuroendocrine Neoplasia.
Ann Clin Lab Sci
; 49(4): 448-456, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31471333
11.
Prognostic and clinical significance of metastasis-associated gene 1 overexpression in solid cancers: A meta-analysis.
Medicine (Baltimore)
; 97(41): e12292, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30313027
12.
Molecular classification of esophagogastric junction carcinoma correlated with prognosis.
Onco Targets Ther
; 10: 4765-4772, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29026322
13.
MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
Oncotarget
; 8(24): 38825-38840, 2017 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28418915
14.
Recombinant adeno-associated virus-delivered anginex inhibits angiogenesis and growth of HUVECs by regulating the Akt, JNK and NF-κB signaling pathways.
Oncol Rep
; 35(6): 3505-13, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27035232
15.
Knockdown of RHOC by shRNA suppresses invasion and migration of cholangiocellular carcinoma cells via inhibition of MMP2, MMP3, MMP9 and epithelial-mesenchymal transition.
Mol Med Rep
; 13(6): 5255-61, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27108649
16.
Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors.
Onco Targets Ther
; 9: 6075-6082, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27785054
17.
HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma.
Oncol Rep
; 34(4): 1681-91, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26260613
Resultados
1 -
17
de 17
1
Próxima >
>>